Latest / Pharmacy Podcast Network / Digital Health Community Pharmacy Innovation: HLTH 2024 Podcast Series | HLTH Part Two
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:08Speaker 1: to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
- 0:24Speaker 2: The Pharmacy Podcast Network is excited to announce the release
- 0:28Speaker 2: of a compelling.
- 0:28Speaker 3: Three part podcast series that covers.
- 0:31Speaker 2: The recent HLGH twenty twenty four conference held in Las
- 0:35Speaker 2: Vegas from October twenty second to the twenty fourth. This
- 0:38Speaker 2: premier event gathered thought leaders and innovators from across the
- 0:41Speaker 2: healthcare landscape, focused on addressing pressing challenges and exploring promising
- 0:46Speaker 2: opportunities for the future of health.
- 0:49Speaker 4: So it's been amazing being at this phenomenal conference. And
- 0:53Speaker 4: what I was thinking last night was, you know, I
- 0:57Speaker 4: grew up in a smaller town and we have a
- 1:00Speaker 4: lake in our town.
- 1:01Speaker 5: It was beautiful.
- 1:02Speaker 4: It's still beautiful, and we were very proud of that lake,
- 1:05Speaker 4: and we were very familiar with that lake. And much
- 1:09Speaker 4: like the first time I did some extensive travel and
- 1:15Speaker 4: I first saw the ocean along the coast of California,
- 1:20Speaker 4: it was eye opening, lit a bit mind blowing, and
- 1:25Speaker 4: I feel like I have that same experience here at
- 1:28Speaker 4: the health conference.
- 1:29Speaker 3: You know, the.
- 1:29Speaker 4: Pharmacy industry community, pharmacy independently owned community pharmacy, which has
- 1:34Speaker 4: been my career, has been this magnificent lake to see
- 1:42Speaker 4: and exist. In coming to this conference, I have been
- 1:46Speaker 4: able to see this bigger ocean, this bigger picture of
- 1:50Speaker 4: innovation in health care, and what it.
- 1:54Speaker 6: Has left moving it.
- 1:56Speaker 4: What it has left me with is really this desire
- 2:02Speaker 4: to progress our independent community pharmacy industry and to exist
- 2:08Speaker 4: in this bigger picture.
- 2:10Speaker 7: Kelly HLT. Some people say health.
- 2:13Speaker 8: I still say HLTH because that's what they originally started
- 2:16Speaker 8: calling it when it was first invented, and now they've
- 2:18Speaker 8: switched to health. But this is my second time here
- 2:23Speaker 8: and I'm still overwhelmed. It's crazy, isn't it.
- 2:26Speaker 7: It's phenomenal.
- 2:28Speaker 4: It's really the best conference I feel like I've experienced
- 2:34Speaker 4: in many, many years.
- 2:36Speaker 8: The energy, the creativity, the injection of people speaking at
- 2:41Speaker 8: all times, and dirt stages that are inside the exhibit hall,
- 2:45Speaker 8: which makes me feel more part of it than always
- 2:48Speaker 8: being separated at some of our traditional conferences. I think
- 2:52Speaker 8: there's something to be learned here from an aesthetics and
- 2:55Speaker 8: a feeling and a vibe because they're practicing what they're preaching,
- 3:00Speaker 8: and they're practicing what they're executing, which is innovation and healthcare.
- 3:05Speaker 8: And I saw pharmacists, We've seen pharmacists IPCs here obviously
- 3:11Speaker 8: representing two thousand and three thousand, you know, pharmacies throughout
- 3:15Speaker 8: the country. How many lives that it's in an impact.
- 3:19Speaker 8: I'm so proud that you've taken the time and you
- 3:21Speaker 8: invested to be here, because just like you said, it's
- 3:25Speaker 8: going from a pond and a lake that you grew
- 3:29Speaker 8: up around and knew, you know, like the back of
- 3:32Speaker 8: your hand, it's beautiful, it's you know, it's part of
- 3:34Speaker 8: the community. But then all of a sudden you realize
- 3:37Speaker 8: there's this whole ocean of opportunity, of innovation, of connection,
- 3:41Speaker 8: and I think that's special. What are you most excited
- 3:47Speaker 8: about when you think of application something that you saw
- 3:50Speaker 8: here and how it can pull back and become valuable
- 3:53Speaker 8: to the community.
- 3:54Speaker 7: Pharmacy are.
- 3:57Speaker 4: There's a lot of tech here, obviously, you know that
- 4:00Speaker 4: AI healthcare tech solutions everywhere you turn. At the end
- 4:08Speaker 4: of that tech solution, at the end of that AI solution,
- 4:12Speaker 4: there's a patient. And for health outcomes to be successful,
- 4:18Speaker 4: patient engagement is key. So community independent pharmacy is excels
- 4:26Speaker 4: in patient engagement. We assess the needs of the patient,
- 4:29Speaker 4: customized that care, we have exceptional customer service, which all
- 4:35Speaker 4: then leads to a higher patient engagement scale. That patient
- 4:40Speaker 4: engagement is critical for any health outcome. I think it's
- 4:44Speaker 4: very exciting that IBC is invested in.
- 4:49Speaker 7: The industry in this.
- 4:50Speaker 4: Way because for these solutions, in these initiatives that we
- 4:58Speaker 4: see all around this year, to exceed the end user,
- 5:03Speaker 4: the patient has to be engaged in them to actually
- 5:07Speaker 4: deliver the results these companies are looking for. And I
- 5:10Speaker 4: think that's where independent pharmacies come in.
- 5:12Speaker 7: Absolutely, absolutely.
- 5:16Speaker 8: The shift from how a independent community pharmacy operated and
- 5:23Speaker 8: knew about it, experienced it twenty years ago. I came
- 5:27Speaker 8: in pharmacy in two thousand and four. I remember this.
- 5:29Speaker 8: I remember the way that I'm not gonna say it
- 5:32Speaker 8: was a simpler time, but in ways it was. And
- 5:36Speaker 8: the generation of revenue to keep your doors open, and
- 5:39Speaker 8: generation of revenue to invest in something else that the
- 5:42Speaker 8: community needs, and generation of revenue for the entrepreneurial driven
- 5:48Speaker 8: pharmacist who knows they have to keep innovating too. That
- 5:54Speaker 8: was just conceptual back then when we were talking about
- 5:58Speaker 8: we used to say predictive model. We used to say
- 6:00Speaker 8: big data, We used to say all these things, and
- 6:05Speaker 8: the health record wasn't talking to the pharmacy system, and
- 6:08Speaker 8: there was no such thing as fire. And now all
- 6:12Speaker 8: of a sudden, you and I are in the smithst
- 6:14Speaker 8: Not to say to the listeners that were old, but
- 6:17Speaker 8: we've been around long enough to remember where it didn't exist.
- 6:20Speaker 8: We also remember when it was used just as a punchline.
- 6:24Speaker 8: And now it's literally happening, like it's really working. It's
- 6:27Speaker 8: touching patients, it's driving care, it's helping pharmacists make money
- 6:32Speaker 8: somewhere else other than the prescription fee. But that is
- 6:37Speaker 8: the future of pharmacy care. I think of that twenty
- 6:40Speaker 8: eighty rule, twenty percent of the revenue coming from something other.
- 6:44Speaker 7: Than the eighty percent, which is prescription fee.
- 6:47Speaker 8: Right ten years from now, when we're here at Health
- 6:50Speaker 8: twenty thirty four, there will be it'll be flipped. It'll
- 6:55Speaker 8: be eighty percent driven services and treatment plans and monitoring,
- 7:00Speaker 8: remote patient care and pharmacogenomics and test kits and all
- 7:03Speaker 8: this stuff of the management and the usage of the
- 7:06Speaker 8: data to drive better preemptive care and then also disease
- 7:10Speaker 8: state management.
- 7:13Speaker 4: I think The other thing when you were talking about
- 7:16Speaker 4: the changes that we've seen at our age as if
- 7:18Speaker 4: you will, is the constant change and that through the
- 7:24Speaker 4: years independent pharmacy pharmacy industry has seen constant change. Sometimes
- 7:30Speaker 4: it feels like it's a daily basis. What's new today,
- 7:32Speaker 4: what's changing today, what obstacle is there, what innovation is available.
- 7:38Speaker 4: I think one of the important things to remember in
- 7:41Speaker 4: a situation like this is that we have to embrace
- 7:44Speaker 4: that change. We look around, we see all these changes
- 7:46Speaker 4: in the industry has to say okay, yes, well we
- 7:50Speaker 4: will step into that change rather than resist it. Because
- 7:56Speaker 4: when we walk into a situation like this and we
- 7:59Speaker 4: see all of these Comeanese that are that are investing
- 8:03Speaker 4: millions billions of dollars into these these technologies that further
- 8:11Speaker 4: patient outcomes, then you know, we have to understand that
- 8:15Speaker 4: we want to be in this room and and there.
- 8:19Speaker 4: If we don't embrace innovation and change in these areas,
- 8:23Speaker 4: then we won't be in this room. You know, I'm
- 8:25Speaker 4: so proud that i PC is in this room. I mean,
- 8:29Speaker 4: we are the only pharmacy the pharmacy independent pharmacy network we're.
- 8:34Speaker 8: In We're in a little pharmacy island over here by ourselves.
- 8:37Speaker 4: Yes, now we've you know, we can see some big
- 8:39Speaker 4: chain names over in the corner, but we we're the
- 8:43Speaker 4: only independent pharmacy representation here and I'm really proud of that,
- 8:48Speaker 4: and we really want to help stores take that step
- 8:52Speaker 4: to embrace this innovation and not just be in the room,
- 8:56Speaker 4: but be a a big impact.
- 9:00Speaker 8: Yeah, let's get a community pharmacy owner up on stage
- 9:04Speaker 8: talking to these physicians, talking to these VC organizations about
- 9:09Speaker 8: what future of pharmacy care looks like at the community level,
- 9:12Speaker 8: at the mom and pop sitting, you know, the people
- 9:15Speaker 8: that have been there for years in their community. How's
- 9:18Speaker 8: that small pharmacy that everybody wants to overlook? How is
- 9:22Speaker 8: it the hub of healthcare and the hub of innovation
- 9:25Speaker 8: in technology? But it's doing it in a gentle manner
- 9:29Speaker 8: because they're already trusted. So, you know, one of the chains,
- 9:33Speaker 8: and God bless the chains. They have to be successful
- 9:36Speaker 8: for public health sake, right, I won't want to see
- 9:38Speaker 8: them fail. But the independent pharmacy can move ten times
- 9:43Speaker 8: faster and implementing something IPC has invested in multi millions
- 9:49Speaker 8: of dollars into systems that not only work, but are
- 9:54Speaker 8: now ready to be connected with other things. We're not
- 9:57Speaker 8: allowed to say, but there are some surprises that are
- 9:59Speaker 8: coming out of this conference that IPC has staged.
- 10:02Speaker 7: I got to.
- 10:02Speaker 8: See behind the scenes stuff with Ashton, and it's exciting.
- 10:07Speaker 8: There's going to be programs that we're going to be
- 10:09Speaker 8: able to plug into the platform that aren't IPC owned.
- 10:13Speaker 8: There are other that are that are consumer wanted, meaning
- 10:16Speaker 8: the consumer wants that program, that health program, and now
- 10:20Speaker 8: the platform that they're already used to can be leveraged
- 10:23Speaker 8: to expand their business through.
- 10:24Speaker 7: These new programs.
- 10:25Speaker 4: Oh, it's exciting. Yeah, we've had we've had some great
- 10:28Speaker 4: conversations and you know, and it's been interesting in these
- 10:32Speaker 4: conversations some of those basic what we see in our
- 10:36Speaker 4: industry as as really the benchmarks of our industry around
- 10:41Speaker 4: our customer service, patient care, total assessment of the whole patient,
- 10:48Speaker 4: increase engagement. You know, these providers, these foundations that are
- 10:57Speaker 4: looking for about our outcomes, they need these things to
- 11:01Speaker 4: actually implement their programs to a successful outcome. I mean,
- 11:06Speaker 4: pharmaces know that like the back of the and so
- 11:10Speaker 4: our challenge now is to.
- 11:14Speaker 7: Accept those and.
- 11:17Speaker 4: Make those changes for greater innovation to bring in those
- 11:21Speaker 4: additional solutions that you were just describing into their service model,
- 11:29Speaker 4: and because what they have now and what they're good
- 11:31Speaker 4: at will make the difference. So to combine those two
- 11:34Speaker 4: I think is a perfect combination.
- 11:37Speaker 8: Absolutely, Kelly, this has been wonderful to be part of
- 11:40Speaker 8: the team. We've had a blast here in Vegas at
- 11:44Speaker 8: hl THH twenty twenty four.
- 11:47Speaker 7: And we're on to Columbus here.
- 11:49Speaker 8: We guess it all right, see there.
- 11:58Speaker 5: Hey, this is doctor Steve Miller, First Data Bank. We're
- 12:01Speaker 5: here at the HLTH conference and I'm here with the Pharmacy.
- 12:04Speaker 8: Podcast Stephen Miller, Doctor Steven Miller, First Data Bank. It's
- 12:10Speaker 8: so exciting to see you here at HLTCH. Thanks for
- 12:13Speaker 8: doing this.
- 12:14Speaker 5: Oh yeah, my pleasure.
- 12:15Speaker 7: All right.
- 12:16Speaker 8: First Data Bank is not a stranger to the Pharmacy
- 12:19Speaker 8: Podcast nor our listeners. We really respect your organization which
- 12:24Speaker 8: you bring to the table. How you alleviate the struggles
- 12:27Speaker 8: of our pharmacists in the realm of using data and
- 12:30Speaker 8: having it makes sense, especially outcomes.
- 12:33Speaker 7: So give our listeners a quick update as.
- 12:37Speaker 8: To you know, what are some of the simultaneous advances
- 12:41Speaker 8: that are rapidly revolutionizing the application of clinical decision support,
- 12:46Speaker 8: which is known as CDs in a medicine specifically as
- 12:49Speaker 8: it applies to medications.
- 12:51Speaker 5: Yeah, this is like my favorite thing to talk about.
- 12:55Speaker 5: I came out of Johns Hopkins a year ago where
- 12:59Speaker 5: I was an assistant professor, and my focus I'm a
- 13:03Speaker 5: pediatric ast anthropology.
- 13:05Speaker 7: We love pediatricians.
- 13:07Speaker 8: Shout out to Jenna Quinn who's actually here with perfecting pets.
- 13:10Speaker 7: Oh, she focuses just on pediatrics.
- 13:12Speaker 5: Yes, yes, I know her. I got really into the
- 13:17Speaker 5: pharmacy decision support space when I was there because as
- 13:22Speaker 5: a pediatric subspecialist working with expensive specialty pharmacy medications, I
- 13:29Speaker 5: was having a terrible time getting my patient's access. I
- 13:34Speaker 5: treated and continued to treat. I'm still in practice a
- 13:36Speaker 5: lot of kids with inflammatory ballel disease that's Crohn's disease
- 13:40Speaker 5: and all sort of colitis, and you have to use medicines,
- 13:44Speaker 5: oral small molecules or injectables, infusion, pharmacy meds that require
- 13:49Speaker 5: prior off and my patients were regularly being hospitalized because
- 13:53Speaker 5: we couldn't get them the meds in a timely man
- 13:56Speaker 5: The process with non transparent it was incredibly painful for
- 14:00Speaker 5: us and the patients and also to be honest, painful
- 14:03Speaker 5: for the payers because of their inefficient processes. In that context,
- 14:08Speaker 5: and with my background as a board certified informatition focused
- 14:13Speaker 5: on human factors engineering and with a lot of coursework
- 14:18Speaker 5: in fire and CDs hooks, I sort of took that
- 14:22Speaker 5: on as a problem, wrote k grant application and started
- 14:26Speaker 5: a consulting business, which eventually led me to come to
- 14:30Speaker 5: FDB about a year ago. And now at FDB, I
- 14:34Speaker 5: get to really spend all of my time focused on
- 14:38Speaker 5: this pharmacy decision support piece. So what then, are the
- 14:43Speaker 5: huge changes in the field that have triggered this revolution
- 14:47Speaker 5: and how pharmacy decision support and how medication decision support happened.
- 14:53Speaker 5: I think that there are really three things. And what
- 14:56Speaker 5: I want to say here is it's not a future
- 15:00Speaker 5: potential revolution that's happening. It's we're mid revolution. It's happening now.
- 15:06Speaker 5: The products that are being used are have been changed
- 15:09Speaker 5: and are continued to be changed because of these things.
- 15:12Speaker 5: So there's three big things. That is fire, fast healthcare, interoperability, resource,
- 15:21Speaker 5: a messaging standard, CDs hooks. Those two things come together
- 15:25Speaker 5: and they're sort of mandated by the twenty first century
- 15:27Speaker 5: Cures Act. There's big common data models that allow you
- 15:32Speaker 5: to take electronic health record or pharmacy health record data
- 15:36Speaker 5: and standardize it and then use it for learning, for
- 15:40Speaker 5: revising our knowledge base, for changing how our alerts and
- 15:44Speaker 5: decision support and trigger. And then there is AI as
- 15:49Speaker 5: of most broadly but more specifically, these large language models
- 15:54Speaker 5: with their machine learning. Those three things which are all
- 15:57Speaker 5: constantly being discussed at health this year, a whole bunch
- 16:00Speaker 5: of talks. Those are the things that are altering the
- 16:03Speaker 5: way in which we're talking about pharmacy here, in which
- 16:07Speaker 5: pharmacists receive the support to make decisions about whether medication
- 16:13Speaker 5: is safe to administer, whether the dose is accurate, whether
- 16:17Speaker 5: it's the right medicine for this patient in their clinical situation,
- 16:22Speaker 5: and whether the cost of the drug at the point
- 16:26Speaker 5: of care, at the point where they're dispensing or administering
- 16:30Speaker 5: it to the patient is reasonable for them with their incredible,
- 16:34Speaker 5: incredible complex mess of the payer infrastructure in the United States.
- 16:38Speaker 5: So those are the things that are changing, and they're
- 16:40Speaker 5: hitting pharmacists right now.
- 16:43Speaker 8: They are, and the scalability need to have technology to
- 16:49Speaker 8: have AI, maybe using AI to to speed up prior
- 16:54Speaker 8: authorizations for example, in even especially cases. But what I'm
- 16:59Speaker 8: thinking of community pharmacy, I'm thinking of eight thousand plus
- 17:02Speaker 8: pharmacies that have disappeared over the last thirty six months,
- 17:06Speaker 8: and it's causing an issue. Therefore, technology is more needed
- 17:09Speaker 8: than ever before. We might have talked about technology five
- 17:12Speaker 8: years ago and said, hey, this is going to be
- 17:15Speaker 8: really cool when this comes out. Now we're saying this
- 17:18Speaker 8: has to work in order for public health to stay.
- 17:22Speaker 7: At par and in order to move forward.
- 17:25Speaker 8: So why is it important for CDs, for those clinical
- 17:29Speaker 8: decision supports to be patient centered and of course scale.
- 17:33Speaker 5: Yeah, So what pharmacists in the ambulatory setting, at these
- 17:39Speaker 5: smaller community pharmacies or bigger community pharmacies whatever, they are
- 17:43Speaker 5: operating in an information poor environment. They don't have everything
- 17:48Speaker 5: that came out of the electronic health record in terms
- 17:51Speaker 5: of information about a patient's disease state or labs or whatever.
- 17:56Speaker 5: They don't necessarily have a knowledge of all of what's
- 18:02Speaker 5: going on with the patient. In terms of social determinants
- 18:04Speaker 5: of health. They've got information about the medications, sometimes limited
- 18:10Speaker 5: indication information, and insurance information, a little bit of demographics.
- 18:15Speaker 5: And so the question is how can a pharmacist take
- 18:19Speaker 5: that information and use it to keep the patient optimally
- 18:23Speaker 5: safe avoiding dangerous drug drug interactions, drug food, drug disease.
- 18:28Speaker 5: All of this kind of information. The way that it
- 18:31Speaker 5: has been done classically is by hitting sort of dumb
- 18:38Speaker 5: database tables with information about each individual drug as it's
- 18:44Speaker 5: the decision is made by the pharmacists to dispense it
- 18:46Speaker 5: or not, and then a giant print out is provided
- 18:52Speaker 5: to the patient that has all kinds of difficult to
- 18:55Speaker 5: understand information to give that What is changing now is
- 19:00Speaker 5: that this new generation of pharmacy informatic systems, which you
- 19:05Speaker 5: know FDB. My company has one, it's called Naviga, which
- 19:09Speaker 5: is currently being used at almost ten thousand, well mid
- 19:14Speaker 5: mid seven thousand pharmacies in the United States. What this
- 19:19Speaker 5: kind of next generation pharmacy information system does is groups
- 19:25Speaker 5: of medication interactions, drug disease, all of these kind of
- 19:29Speaker 5: interactions by clinical consequence and therefore allows pharmacists to make
- 19:37Speaker 5: decisions around which meds to fill not feel provide extra
- 19:43Speaker 5: counseling to patients about at a much more logical point
- 19:48Speaker 5: in their clinical workflow and in a way that pharmacists
- 19:51Speaker 5: think okay. Is this going to trigger the patient to
- 19:54Speaker 5: have a kidney injury. Rather than just looking in a
- 19:57Speaker 5: drug focused manner, next generation system looks in a patient
- 20:02Speaker 5: focused manner and allows them to first off, get the
- 20:07Speaker 5: information at the right point in their workflow at validation
- 20:10Speaker 5: or prior to the moment of clicking the dispense, clicking
- 20:15Speaker 5: through the dispense in their system, and secondly provides it
- 20:21Speaker 5: in a very patient specific manner. And then the third
- 20:23Speaker 5: thing is providing patients health information about their meds in
- 20:31Speaker 5: common language in a manner that they can fill it
- 20:37Speaker 5: and get a schedule, get information about how they're going
- 20:41Speaker 5: to actually incorporate this into their daily life. That information
- 20:46Speaker 5: standard schedules, packaged medication inserts at fifth to eighth grade
- 20:51Speaker 5: reading level in multiple languages. I mean, we haven't talked
- 20:53Speaker 5: about that stuff, but those things are now possible and
- 20:58Speaker 5: are being done in many format sees across the United States.
- 21:02Speaker 5: A number of companies are providing this, and FDB is
- 21:06Speaker 5: one of them that is really at the forefront of.
- 21:08Speaker 7: This, Steve.
- 21:10Speaker 8: The evolution of pharmacy care is under pressure because.
- 21:14Speaker 7: Of things that we've already kind of discussed.
- 21:16Speaker 8: So something that is necessary is empowering the individual pharmacist
- 21:23Speaker 8: who acts as a consultant to a group of patients
- 21:26Speaker 8: who have been assigned through like a Medicaid arrangement for example.
- 21:31Speaker 8: And now we're seeing the rise of this in my
- 21:33Speaker 8: own state, Pennsylvania, in a little town called Meadville, Pennsylvania.
- 21:38Speaker 8: Doctor thea bleistone has a group of patients about two
- 21:41Speaker 8: hundred and fifty that rely on her for medication reviews.
- 21:44Speaker 8: Guess what zero dispensing involved? And she's still being paid
- 21:48Speaker 8: as a pharmacist. And I think of clinical support, clinical
- 21:52Speaker 8: decision support in her bag, in her tote, so she
- 21:55Speaker 8: can pull that out and actually extract it. How do
- 21:58Speaker 8: we start empowering an individual pharmacist driven by an NPI
- 22:02Speaker 8: because they all have MPIs to be able to say hey,
- 22:05Speaker 8: through a physician agreement incident two agreement, we now have
- 22:09Speaker 8: this pharmacist that gives us three hundred patients that are
- 22:13Speaker 8: being managed by them. How does clinical support start trickling
- 22:16Speaker 8: down to the individual pharmacist.
- 22:18Speaker 5: Yeah, and I don't think that this is like something
- 22:23Speaker 5: that is a one off in Pennsylvania. We're seeing this
- 22:25Speaker 5: across the whole country and across the whole world, and
- 22:28Speaker 5: it's we talked about the pharmacist shortage, which is acute,
- 22:31Speaker 5: but the position shortage is also there, and classically, physicians
- 22:36Speaker 5: have had to manage a bunch of health conditions that
- 22:40Speaker 5: in some cases would be better managed by pharmacists who
- 22:44Speaker 5: understand how the drugs work and the pharmacokinetics and pharmacodynamics
- 22:49Speaker 5: of these meds. Sometimes there's a bunch of chronic conditions
- 22:53Speaker 5: in some cases, things like diabetes, kredic kidney disease. There's
- 22:57Speaker 5: a bunch of these conditions that pharmasists are currently being
- 23:01Speaker 5: empowered in many places to manage. In Canada they're ahead
- 23:07Speaker 5: of us on this issue, and there's a couple of
- 23:09Speaker 5: European countries. But FTB in Canada has a product that
- 23:15Speaker 5: we use that provides algorithmic, guideline based decision support to
- 23:21Speaker 5: pharmacists in the management of some of these chronic conditions
- 23:25Speaker 5: where they are tight trading drug levels, which pharmacists are
- 23:30Speaker 5: better at than mds in a lot of cases because
- 23:32Speaker 5: they're so to have such a deep drug knowledge and
- 23:35Speaker 5: or so drug focus, where pharmacists are able to use
- 23:38Speaker 5: these tools to ty trade medication dosages and levels and
- 23:44Speaker 5: it empowers these pharmacists to manage and make treatment decisions,
- 23:49Speaker 5: certainly in collaboration with doctors, but often fully independently from doctors.
- 23:53Speaker 5: And this is a product that we are rolling out
- 23:56Speaker 5: in the United States as well to be able to
- 24:00Speaker 5: support pharmacists in providing this kind of high level decision
- 24:04Speaker 5: support for their patients.
- 24:06Speaker 8: Steve, you have to promise to come back and we'll
- 24:09Speaker 8: dig into this because I want to bring in consultant
- 24:12Speaker 8: pharmacists who are focused on geriatrics. Let's bring Jenna Quinn back,
- 24:16Speaker 8: doctor Quinn, Let's talk about pediatrics. Let's bring in specialty
- 24:20Speaker 8: pharmacy to talk about rare disease. You're everywhere in those
- 24:24Speaker 8: spaces and the clinical decision support is so important. So
- 24:28Speaker 8: thank you so much for being part of the HLT
- 24:30Speaker 8: twenty twenty four show.
- 24:31Speaker 5: My pleasure's great to talk to you.
- 24:38Speaker 8: Fallin' Banyez back on the Pharmacy Podcast.
- 24:42Speaker 7: It's so good to have you back on.
- 24:44Speaker 6: It's great to be back.
- 24:45Speaker 8: All right, we are here at HLTCH twenty twenty four.
- 24:49Speaker 8: The events here are just supercharged. I get so excited
- 24:53Speaker 8: being here. This is my second time. It's actually twice
- 24:56Speaker 8: as big as what it was in twenty twenty two.
- 24:59Speaker 7: I don't know how they can growing like this.
- 25:00Speaker 9: Yeah, I believe it. It's pretty exciting out.
- 25:02Speaker 7: Here, all right, I want to jump in.
- 25:05Speaker 8: So doctor first is an incredibly important part of the
- 25:09Speaker 8: evolution of digital health and the fusion into healthcare. You
- 25:13Speaker 8: and I are going to talk a little bit about
- 25:14Speaker 8: community pharmacy and digital health, But first.
- 25:17Speaker 7: I do want to just for the listeners.
- 25:19Speaker 8: Perspective, why is it imperative to the industry to unite
- 25:23Speaker 8: medical and pharmacy benefits.
- 25:26Speaker 9: Yeah, I mean, think about the growth of specialty medications
- 25:31Speaker 9: even within the last two or three years, specially medication
- 25:35Speaker 9: drug development. Specialty medication application is skyrocketing, you know, thousands
- 25:42Speaker 9: of percent actually, And there's actually an important distinction between
- 25:47Speaker 9: the two sides of the benefit coin the pharmacy benefit.
- 25:50Speaker 9: I feel like most of America, most of our patient
- 25:53Speaker 9: population understands, or at least can wrap their head around
- 25:56Speaker 9: the idea of a pharmacy benefit. But the idea of
- 26:00Speaker 9: certain drugs being covered under medical benefit gets confusing and
- 26:05Speaker 9: people don't.
- 26:06Speaker 6: Quite understand that.
- 26:07Speaker 9: And the amount of drugs, the number of drugs that
- 26:11Speaker 9: are now falling under that medical benefit is also skyrocketing,
- 26:16Speaker 9: and so in the universe of transparency and making things
- 26:21Speaker 9: simple and navigating all of the friction that's already inherent
- 26:26Speaker 9: in healthcare.
- 26:28Speaker 6: Why don't we have an ability.
- 26:30Speaker 9: To combine the view into both of those benefits on
- 26:33Speaker 9: behalf of the patient, on behalf of the doctor. It's
- 26:37Speaker 9: so complicated already. Let's ease that complication. And so these
- 26:42Speaker 9: things are growing, these things are increasing in complexity. Let's
- 26:45Speaker 9: leverage technology to improve that transparency.
- 26:48Speaker 6: For all players in this ecosystem.
- 26:51Speaker 8: All right, So we know there's an explosion unfortunately, of
- 26:54Speaker 8: pharmacy deserts in the country, twenty four hundred just in
- 26:58Speaker 8: the last twelve months that are shouting down pals than
- 27:01Speaker 8: in the last thirty six months. So technology is so
- 27:05Speaker 8: crucial and more important than it's ever been before.
- 27:08Speaker 7: Doctor First steps up.
- 27:09Speaker 8: So we see that you're currently as that load on pharmacists.
- 27:14Speaker 8: As that intensity kind of intensifies, they're going to have
- 27:17Speaker 8: to put out more to keep up with the population's needs.
- 27:21Speaker 8: So talk to us about that technology and how it's
- 27:24Speaker 8: helping through Doctor First.
- 27:26Speaker 9: Yeah, I mean, we're all being asked to do more
- 27:28Speaker 9: with less. The pharmacy desert problem is real, it's scary,
- 27:33Speaker 9: and it's affecting Unfortunately, it's affecting folks that are already
- 27:37Speaker 9: underprivileged the most, in my opinion. And so in order
- 27:43Speaker 9: to do more with less, you're going to have to
- 27:44Speaker 9: find a force multiplier. You're going to have to find something,
- 27:48Speaker 9: and that's something is typically technology. So health information technology
- 27:52Speaker 9: has the opportunity to serve as that enforce multiplier. And
- 27:55Speaker 9: we're talking about things like automation. We're talking about things
- 27:59Speaker 9: like the thoughtful application of clinical grade AI, very narrow
- 28:05Speaker 9: focused AI to solve very specific problems. Whether that's improving
- 28:11Speaker 9: the throughput of a dispensing pharmacy, whether that's improving the
- 28:15Speaker 9: accuracy of a pharmacy technician doing medication reconciliation, whether it's
- 28:21Speaker 9: improving the efficiency of something as frustrating as a prior authorization.
- 28:27Speaker 6: All of these.
- 28:28Speaker 9: Things lend themselves to technology, and right now we're at
- 28:31Speaker 9: a crucial inflection point for technology in the application of
- 28:36Speaker 9: pharmacy services. So it's actually a very exciting time and
- 28:40Speaker 9: it couldn't come fast enough in light of these things
- 28:42Speaker 9: that you just brought up, like pharmacy deserts.
- 28:45Speaker 8: Absolutely, so I think of you know, we're at AHLT.
- 28:49Speaker 8: This represents all of healthcare, not just the sectors that
- 28:52Speaker 8: we kind of dive into in pharmacy. We go to
- 28:55Speaker 8: long term care conferences. Sometimes we'll head to specialty. I
- 28:59Speaker 8: just got by from the NSP, the National Association of
- 29:02Speaker 8: Specialty Pharmacy.
- 29:04Speaker 7: You have something special within.
- 29:05Speaker 8: The portfolio of what Doctor First is doing in specialty pharmacy.
- 29:09Speaker 7: Let's talk about that.
- 29:10Speaker 8: How's that technology helping prior authorizations to speed up those
- 29:14Speaker 8: processes to get people their first fill and then so on.
- 29:17Speaker 6: Yeah.
- 29:17Speaker 9: I like to use two buzzwords when talking about the
- 29:21Speaker 9: Doctor First portfolio. One is total benefits management. So remember
- 29:27Speaker 9: we started this conversation the distinction of pharmacy versus medical.
- 29:30Speaker 6: Yep, we have a solution that actually encompasses both.
- 29:34Speaker 9: So input your service and put your you know, predicted prescription,
- 29:40Speaker 9: and no matter which way it's covered, we're gonna tell
- 29:41Speaker 9: you the answer. We're gonna tell you the cope, We're
- 29:43Speaker 9: gonna tell you where you are in your deductible etc.
- 29:47Speaker 9: Is total benefits management. It's not go here for one
- 29:50Speaker 9: and go there for somewhere else. It's actually a consolidated
- 29:53Speaker 9: view on behalf of the of the provider and actually
- 29:57Speaker 9: on the pair side as well, should they opt to
- 29:59Speaker 9: use it. The other I like to talk about is
- 30:01Speaker 9: end to end optimization of workflow.
- 30:04Speaker 6: So doctor first is uniquely positioned.
- 30:07Speaker 9: In that we have a piece of every part of
- 30:11Speaker 9: the workflow for a specialty medication, whether it's inception, the
- 30:15Speaker 9: idea of me as a physician needing to write for
- 30:18Speaker 9: that prescription, all the way to you know, helping the
- 30:21Speaker 9: patient pick it up, engage in that prescription, afford that prescription,
- 30:25Speaker 9: and then even afterwards in terms of measuring adherents and
- 30:28Speaker 9: things like that. And so this is a really exciting
- 30:31Speaker 9: time for doctor First because the portfolio is actually growing,
- 30:34Speaker 9: and it's growing in a direction that is meeting the
- 30:37Speaker 9: needs of market demand.
- 30:39Speaker 8: Listeners reach out to the doctor first team, Colin. Where's
- 30:44Speaker 8: the best place to push our listeners?
- 30:47Speaker 9: Doctor first dot com is the easiest way. A beautiful website.
- 30:51Speaker 9: I'm also readily available. You can find me on x
- 30:54Speaker 9: formerly known as Twitter, LinkedIn. I'm sure we'll link to
- 30:58Speaker 9: all of those various things, but we're very accessible and
- 31:02Speaker 9: I'm happy to talk to anyone.
- 31:04Speaker 7: This has been wonderful to re engage with you, Colin.
- 31:07Speaker 8: I always love your insights. We've got to have you
- 31:09Speaker 8: back on another show. We'll dig deeper into specialty.
- 31:12Speaker 6: I love it, you know me. I'm up for anything,
- 31:14Speaker 6: all right.
- 31:15Speaker 7: Colin Vanaz with Doctor First, thank you so much.
- 31:17Speaker 6: Hey, thanks for having me.
- 31:24Speaker 7: Rick Gates here with Walgrains at HLTCH. Thanks for being
- 31:28Speaker 7: part of the post show that.
- 31:29Speaker 6: It's great to be with you.
- 31:30Speaker 7: All right. So, you know, this is a tough time
- 31:34Speaker 7: in pharmacy.
- 31:35Speaker 8: We have eight thousand less pharmacies now in the United
- 31:38Speaker 8: States that we had three years ago.
- 31:40Speaker 7: Pharmacists are under pressure.
- 31:43Speaker 8: You know, when I think of HLTH, I think, how
- 31:46Speaker 8: do we infuse digital health, with technology, with workflow with
- 31:51Speaker 8: pharmacists to alleviate some of that stress so they can
- 31:54Speaker 8: concentrate on the patients and what the patients really need.
- 31:58Speaker 8: This is what Walgreens professes. I've read blogs about it.
- 32:02Speaker 8: I've listened to remedia Tandon talk about the importance of
- 32:05Speaker 8: clinical trials at the community level. Rick Gates, this is
- 32:09Speaker 8: why you're here. Talk to us about what Walgreens is.
- 32:12Speaker 7: Doing in the face of all this adversity.
- 32:15Speaker 10: And I know you're saying it's diversity, but I'd say
- 32:16Speaker 10: it's just a changing consumer dynamic.
- 32:18Speaker 7: It's really happening right now.
- 32:20Speaker 10: And I think our ability to kind of change and
- 32:23Speaker 10: evolve our operating model to really solve that, and solve
- 32:25Speaker 10: it in two different ways. One that's easier for consumer,
- 32:28Speaker 10: but then the second is how do we make it
- 32:29Speaker 10: easier for our practitioners and team members as well? And
- 32:33Speaker 10: so I think we have to invest differently. And I
- 32:35Speaker 10: think what you're seeing is to invest in our ways
- 32:37Speaker 10: like micro fulfillment to fill strips outside and put them
- 32:40Speaker 10: back in stores so that our pharmacists and technicians.
- 32:42Speaker 7: Can deal more with consumers on a consistent basis.
- 32:45Speaker 10: You also have centralized services where we're can take hundreds
- 32:48Speaker 10: of thousands of calls a day out of our stores,
- 32:50Speaker 10: service them so for patients, but then again leave time
- 32:53Speaker 10: in stores. I think we've made a lot of investments
- 32:55Speaker 10: to start to support some of our stores, but we're
- 32:57Speaker 10: not quite there yet for the full fleet. The other
- 33:01Speaker 10: thing I'd say is a lot of the digital enhancements
- 33:03Speaker 10: that we're trying to do, we're going to make it
- 33:04Speaker 10: easier for consumers that conversely make it easier for our
- 33:07Speaker 10: team members. So I hear all the time when I
- 33:09Speaker 10: walk into a store, I might see a line, right,
- 33:11Speaker 10: how do we actually solve for the things that consumers
- 33:13Speaker 10: don't want. So one way is actually something called digital
- 33:16Speaker 10: check it, So we're testing it this year with vaccinations.
- 33:20Speaker 10: You scan yourself, you less know you're there. It actually
- 33:22Speaker 10: goes straight back into the pharmacy staff, so they know
- 33:24Speaker 10: that you're there, checked in for your appointment. You've already
- 33:26Speaker 10: done all of your digital bars and stuff online, so
- 33:29Speaker 10: that we know that you're ready. We just walk out
- 33:31Speaker 10: and call your name and go in and do the vaccination.
- 33:34Speaker 10: How do we do that for any time you're going
- 33:35Speaker 10: to engage with us? How do we actually have you
- 33:38Speaker 10: communicate to us before you head to the pharmacy that
- 33:39Speaker 10: you're on your way down so that we can kind
- 33:41Speaker 10: of get everything you're ready, set up our team members
- 33:43Speaker 10: in a different.
- 33:43Speaker 9: Way to really be much more successful.
- 33:46Speaker 10: And then the third thing I'd say is we're using
- 33:48Speaker 10: data differently, So how do we actually take data for
- 33:50Speaker 10: how stores are operating, or for what the right types
- 33:53Speaker 10: of interventions we have for patients and get smarter about
- 33:56Speaker 10: how we deploy that time.
- 33:57Speaker 6: And now we're fere out.
- 33:58Speaker 10: For our pharmacists to do something different with that patient
- 34:01Speaker 10: that's there, So maybe just not the one thing they
- 34:03Speaker 10: can there for, but there may be three or four
- 34:05Speaker 10: things that could be get care closures or things that
- 34:07Speaker 10: are going to be important that we want to put
- 34:09Speaker 10: in front of our pharmacists. And I think use of
- 34:11Speaker 10: AI or machine learning or however you want to look
- 34:13Speaker 10: at it.
- 34:14Speaker 6: We're aggregating data to really.
- 34:15Speaker 10: Do something different and help enable better outcomes for our patients.
- 34:19Speaker 8: So I'm also thinking of the serious Z state conditions
- 34:23Speaker 8: that pharmacists are tasks that really helping to manage. You
- 34:27Speaker 8: grab the football from the physician, you implement the treatment,
- 34:32Speaker 8: you move it forward, making sure that they're adherent, maybe
- 34:36Speaker 8: involving them in some kind of metapp on their phone
- 34:39Speaker 8: so that they can interact with Walgreens talk to us
- 34:42Speaker 8: about Z state management and how Walgreens is handling that
- 34:45Speaker 8: for your communities.
- 34:46Speaker 6: Well, I think there's two things.
- 34:48Speaker 10: One is you've got to make sure you've got the
- 34:50Speaker 10: relationship with a physician, which I think is important. And
- 34:52Speaker 10: obviously I think we all know somebody that's left the
- 34:55Speaker 10: hospital or whatever and they have a whole sheet of medication,
- 34:58Speaker 10: so they have to take right. The best thing you
- 34:59Speaker 10: can do to make sure your pharmacists really help reconcile
- 35:02Speaker 10: the medications to you at home versus what you just
- 35:04Speaker 10: got prescribed, and then help start them down the journey
- 35:07Speaker 10: because I think we all know, you know, one of
- 35:09Speaker 10: the scariest moments is when you first get diagnosed with
- 35:11Speaker 10: any disease states, if you will, And so getting people
- 35:14Speaker 10: on therapy and helping them stay in therapy is the
- 35:16Speaker 10: most critical thing that we do, and I think that's
- 35:18Speaker 10: probably where we focus most when it comes to disease states,
- 35:22Speaker 10: because once you get them on treated and staying on therapy,
- 35:25Speaker 10: I think then it's easier to help them understand other
- 35:28Speaker 10: things around that morbidity or that disease state that is
- 35:31Speaker 10: going to help them. And so I think that's probably
- 35:33Speaker 10: the biggest focus is getting on and staying on therapy
- 35:36Speaker 10: once you actually get diagnosed with.
- 35:37Speaker 7: A disease HL.
- 35:39Speaker 8: Why is Walgreens invested in this conference? This thing is amazing.
- 35:43Speaker 7: I love coming. This is my second time here. Talk
- 35:46Speaker 7: to us about this organization in your participation, yea.
- 35:49Speaker 10: Our participation is this is where innovations happen, right, I
- 35:52Speaker 10: think is walgrains. You know, we're not going to build
- 35:55Speaker 10: everything on a row, and we're not going to just
- 35:56Speaker 10: solve everything within the four walls of Walgreens. I think
- 35:59Speaker 10: that what we're really trying to gas understand who's really
- 36:01Speaker 10: moving the needle differently, who can we partner with and
- 36:04Speaker 10: how do we actually drive innovation within the almost one
- 36:08Speaker 10: hundred and twenty five year old company in a different
- 36:10Speaker 10: way than we have before. And so for me, I
- 36:12Speaker 10: just love getting different ideas. I love meeting people that
- 36:15Speaker 10: are really pushing the envelope and then figuring out how
- 36:17Speaker 10: do we work together to really drive something difficult.
- 36:20Speaker 7: Rick Gates, this has been special to us.
- 36:22Speaker 8: I want to thank you so much for being part
- 36:23Speaker 8: of the HLTH post show. I want to invite you
- 36:26Speaker 8: back and let's dig into some of the issues that
- 36:28Speaker 8: our communities are facing.
- 36:29Speaker 10: Absolutely, it's great to be here.
- 36:31Speaker 7: Thank you.
- 36:31Speaker 10: Right now.
- 36:33Speaker 7: Awesome.
- 36:39Speaker 11: This is Michael Mann at Planetary Health first of Mars
- 36:42Speaker 11: Next and I am right now tuning into the only
- 36:47Speaker 11: the Pharmacy Podcast Network, The Pharmacy Podcast Network.
- 36:51Speaker 3: Cool Todd, Awesome to be here with you.
- 36:53Speaker 7: Ben Hey, Michael, it's special to see you here.
- 36:56Speaker 8: This is a different environment every time I come to conferences.
- 36:59Speaker 8: It's around pharmacists, maybe in geriatrics, maybe it's in just
- 37:04Speaker 8: general HLTH. Is this collaborative of digital health folks who
- 37:09Speaker 8: really want solutions. We're here because we want to infuse
- 37:13Speaker 8: digital health with community pharmacy, and we want answers immediately.
- 37:18Speaker 8: The reason is eight thousand less pharmacies today than where there.
- 37:22Speaker 7: Were eight three years ago.
- 37:25Speaker 8: So we're in a tense, crucial time for public health.
- 37:28Speaker 7: I just want your insights on that.
- 37:30Speaker 11: So when I think of a pharmacist, I think of
- 37:33Speaker 11: not just you know, back in the day when you
- 37:36Speaker 11: it was like your you know, church, your family member,
- 37:42Speaker 11: but man, that pharmacist was like where you went for everything.
- 37:46Speaker 3: And so even when I was a little kid.
- 37:48Speaker 11: But I'm also thinking back to when I was, you know,
- 37:50Speaker 11: listening to my father's stories in the small town.
- 37:53Speaker 3: It's like he was a soda jerk at the local pharmacy.
- 37:55Speaker 3: So it was a hub of everything.
- 37:56Speaker 11: Yeah, And so you're losing that community trust because physicians
- 38:00Speaker 11: can't do everything, and a pharmacist is usually the lifeguard
- 38:04Speaker 11: for every person who's going in to knowe, hey did
- 38:07Speaker 11: my cardiologists, did my doctors prescribe the right medication?
- 38:11Speaker 3: Or what should I be on?
- 38:12Speaker 11: So it's like the first and only last resort of trust.
- 38:15Speaker 11: So I think we need to do a lot more
- 38:18Speaker 11: to empowering, you know, to try to change that that
- 38:23Speaker 11: that I guess where that's going that cycle.
- 38:26Speaker 3: So how can we do that? I don't know that answer.
- 38:28Speaker 8: So there are some dynamic players out there who are
- 38:31Speaker 8: not waiting for permission. They're they're asking for forgiveness. They say,
- 38:37Speaker 8: we're not waiting. One of those is Sean Narron with AQUX.
- 38:41Speaker 8: He doesn't wait for anyone to tell him what he
- 38:44Speaker 8: can or cannot do with his patient who's locked in
- 38:47Speaker 8: their home most of the time, he can't get out
- 38:49Speaker 8: to get their.
- 38:50Speaker 7: Own medication and care.
- 38:52Speaker 8: That's the kind of model that we're going to have
- 38:54Speaker 8: to move forward with and expand upon throughout these communities
- 38:57Speaker 8: that now don't have a pharmacy five miles away. The
- 39:00Speaker 8: nearest pharmacy is fifteen miles away. And guess what, public
- 39:04Speaker 8: transportation doesn't go there. So now it enters a car
- 39:09Speaker 8: X with transportation, with delivery, with oversight, with remote patient monitoring.
- 39:13Speaker 7: That's the future of community farmacy.
- 39:15Speaker 11: Yeah, I love that. And I know Sean. I've had
- 39:17Speaker 11: him on my show before. He's just an awesome guy,
- 39:20Speaker 11: and I know from what he's doing is not what
- 39:23Speaker 11: he was, he's just accelerating this.
- 39:25Speaker 8: He was in grocery store pharmacy and now he's transformed
- 39:28Speaker 8: into this.
- 39:29Speaker 7: Yeah, it's like a quasei home.
- 39:32Speaker 8: Care slash long term care slash community pharmacy, and it's awesome.
- 39:36Speaker 3: I would hope that he can lock in with the payers.
- 39:39Speaker 11: It's sort of that new way of where we're going
- 39:41Speaker 11: to be delivering healthcare.
- 39:43Speaker 8: Yeah, exactly, absolutely, all right, we're at HLTH. What's something
- 39:48Speaker 8: that you're focused on while you're here?
- 39:49Speaker 5: What's important to you do?
- 39:51Speaker 11: Well, I'm really excited that we're doing media. We're approved
- 39:53Speaker 11: media here.
- 39:54Speaker 3: The podcast congratulations, Yeah, thank you so much.
- 39:57Speaker 11: We've done about one hundred and thirty episodes almost on
- 39:59Speaker 11: two years, and trying to do more panel discussions. Brought
- 40:03Speaker 11: on a physician senior physician contributor, doctor Alissa Abo suzie Ingwald,
- 40:09Speaker 11: kind of bringing that medtech advisor perspective, and we've been
- 40:13Speaker 11: doing a lot of discussions today.
- 40:15Speaker 3: We'll be doing a lot more.
- 40:16Speaker 11: Discussions tomorrow, and the Village media here really thankful and
- 40:20Speaker 11: appreciative to Health for allowing us to be here and
- 40:24Speaker 11: just meeting a lot of awesome people like yourself. The
- 40:27Speaker 11: startup founders, people that want to see change and doing
- 40:31Speaker 11: really cool stuff. A lot of AI talk, but just
- 40:35Speaker 11: just being energized really by these discussions.
- 40:38Speaker 8: All Right, I'm going to make a call out to
- 40:41Speaker 8: pharmacist listeners that are listening right now. I want them
- 40:44Speaker 8: to reach out to you and become part of your
- 40:46Speaker 8: programming throughout twenty twenty five. If you're listening and you
- 40:50Speaker 8: have a passion about pediatrics or cardiology, or HIV or
- 40:56Speaker 8: women's health, whatever, reach out to Michael Man. He'll get
- 40:59Speaker 8: you tied into a theme where he's not just talking
- 41:02Speaker 8: to one person, he's talking to a whole panel of people.
- 41:05Speaker 8: You guys are good at that whole panel discussion thing.
- 41:07Speaker 8: So I think that fusion is really important.
- 41:09Speaker 11: Yeah, I really appreciate it, Todd, and it's been good
- 41:12Speaker 11: to have you on.
- 41:12Speaker 3: We've we've exchanged as well. You've come on my show.
- 41:16Speaker 11: And what I like about the panel is because we're content,
- 41:21Speaker 11: we're the new wave of educating and by content meaning
- 41:24Speaker 11: it's real, it's not scripted. Of course, we'll have a
- 41:27Speaker 11: topic kind of stay off that you know, have some guardrails,
- 41:30Speaker 11: but really it's creating real innovation, spitballing and creating what
- 41:35Speaker 11: conversations that can really help others be empowered and then
- 41:39Speaker 11: kind of just enlisting others to kind of participate with
- 41:42Speaker 11: us in this journey.
- 41:43Speaker 8: Matthew, thank you so much for being part of the
- 41:45Speaker 8: HLTH coverage here at twenty twenty four. We hope to
- 41:48Speaker 8: meet up with you next year. Listeners are going to
- 41:51Speaker 8: want to learn more. Where should they go to learn
- 41:53Speaker 8: more about idea.
- 41:54Speaker 3: Ideo dot com?
- 41:56Speaker 6: Nice and straight frough with www ideo dot com and
- 42:00Speaker 6: you'll find everything you need to know there about the
- 42:03Speaker 6: future of human sentiity.
- 42:09Speaker 12: This is doctor Russell Robins from Purple Lab and you're
- 42:12Speaker 12: listening to the Pharmacy podcast.
- 42:17Speaker 7: Purple Lab is back.
- 42:19Speaker 8: We just got to interview doctor Russell Robbins at the
- 42:23Speaker 8: NASP talking about specialty pharmacy and I missed you, Russell.
- 42:29Speaker 7: I was not able to spend time.
- 42:31Speaker 8: Here yesterday because I had a bag disaster. I loaded
- 42:35Speaker 8: all of my luggage into my lift and my equipment.
- 42:38Speaker 7: Bag fell out of the car. Nobody knew it.
- 42:42Speaker 8: I drove to the hotel. He gives me one bag.
- 42:45Speaker 8: I'm like, dude, where's my equipment bag. We had to
- 42:48Speaker 8: go back to the airport. I was saying hell, Mary
- 42:51Speaker 8: and our fathers the entire way to the to the airport.
- 42:55Speaker 7: The Lord blessed me.
- 42:56Speaker 8: They found the bag it was in in in lost
- 42:59Speaker 8: and oh that's great, Welcome to Vay.
- 43:01Speaker 12: Well, absolutely, that was like my travel experience. I was
- 43:05Speaker 12: actually in Vegas last week Tuesday to Thursday for the
- 43:09Speaker 12: AMCP conference, and I was supposed to get here at
- 43:14Speaker 12: one o'clock in the afternoon, got on the first on
- 43:16Speaker 12: the flight, and they had a mechanical we got delayed,
- 43:19Speaker 12: and so instead of getting it at one, we got
- 43:20Speaker 12: in at nine o'clock at night.
- 43:22Speaker 6: Oh my gosh.
- 43:23Speaker 12: So luckily the presentation was the next day, so everything
- 43:27Speaker 12: worked out fine, and then came went home Thursday, came
- 43:31Speaker 12: back again Saturday.
- 43:32Speaker 8: Yeah, this is travel season for US three conferences and
- 43:35Speaker 8: then in October Purple Lab's been important to our network
- 43:39Speaker 8: because you've been bringing discussions and ideas around things that
- 43:43Speaker 8: we're just not getting enough information on. I missed your
- 43:46Speaker 8: panel discussion yesterday here at HLTH give our listeners a
- 43:51Speaker 8: little summary of that panel discussion.
- 43:52Speaker 5: Short.
- 43:53Speaker 12: So, what we were talking about yesterday was health plans
- 43:57Speaker 12: and wellness and preventive care and how health plans are
- 44:01Speaker 12: using data for understanding wellness programs and preventive care, but
- 44:07Speaker 12: then also with the Purple Lab data that we have
- 44:10Speaker 12: access to, with the social determines of health information, of
- 44:15Speaker 12: using that to really shed different types of lights on
- 44:20Speaker 12: immunization rates and other types of preventive care that individuals
- 44:27Speaker 12: you're getting.
- 44:28Speaker 8: So when I think of the follow up that pharmacists
- 44:32Speaker 8: are kind of listening to the data that you make available,
- 44:35Speaker 8: and I think of the collection of the medical record
- 44:40Speaker 8: side of things, and all of a sudden, the pharmacist responds,
- 44:43Speaker 8: what studies has Purple Lab done to show the necessity
- 44:47Speaker 8: to make sure that the data is coming back from
- 44:50Speaker 8: the pharmacist to the electronic health record? Has there been
- 44:52Speaker 8: anything that you've operated on that kind of shows the validity?
- 44:55Speaker 12: So we don't do much with We don't do anything
- 44:58Speaker 12: at this point with electronic health records. We don't have
- 45:00Speaker 12: any We just take claims that have already been adjudicated,
- 45:03Speaker 12: so we don't have any insights into what's going on
- 45:07Speaker 12: at the point of contact. We only know after it's
- 45:10Speaker 12: been adjudicated, after it's been paid, or if it was
- 45:13Speaker 12: rejected or denied, we know that information. So you know,
- 45:17Speaker 12: so from a pharmacy perspective, we have ways to track
- 45:20Speaker 12: the patient journey throughout the process, looking at you know,
- 45:24Speaker 12: for any given drug, did they patient get the medication,
- 45:28Speaker 12: did they abandon the medication at the retail window, and
- 45:32Speaker 12: or was that medication denied and if so, what were
- 45:35Speaker 12: the reasons for that. With the social determines of health information,
- 45:39Speaker 12: we can then look to see what kind of demographics
- 45:43Speaker 12: fall into each of those different categories and come up
- 45:45Speaker 12: with potential solutions for how to mitigate some of those
- 45:49Speaker 12: issues as well. At the panel discussion yesterday, you know,
- 45:52Speaker 12: one of the questions, of course is with preventive care
- 45:55Speaker 12: and immunization rates, you know, how do we look at
- 45:58Speaker 12: that and how do the health plant use that information?
- 46:01Speaker 12: And years ago, right when the COVID pandemic started, one
- 46:05Speaker 12: of the questions that I was asking when they were
- 46:08Speaker 12: first talking about, you know, we need to develop some
- 46:10Speaker 12: type of vaccine is what's the likelihood that these vaccines
- 46:14Speaker 12: would be utilized? And so we looked and I said,
- 46:18Speaker 12: you know, there's really three different.
- 46:19Speaker 5: Categories of vaccinations.
- 46:21Speaker 12: And you know, this gets back to preventive care. You
- 46:23Speaker 12: have the pediatric population, so most parents are going to
- 46:26Speaker 12: make sure that the kids get immunized for those type
- 46:30Speaker 12: of things. Then you have the adolescent population, so you know,
- 46:33Speaker 12: they're getting the HPV vaccines, they're getting the meningitis.
- 46:37Speaker 7: Vaccine, sports athletics and stuff.
- 46:39Speaker 12: So with those types of things, you know, there's a
- 46:42Speaker 12: little more parental you know, questioning.
- 46:45Speaker 3: Should I do this or not do this?
- 46:47Speaker 5: And so you see some drop off there.
- 46:49Speaker 12: And then you have the third group, which is for adults,
- 46:52Speaker 12: you know, the shingles vaccine, the numavacs, and so you
- 46:55Speaker 12: can see, you know, when it's my own personal decision
- 46:58Speaker 12: to make, you know, you can see this repency, you
- 47:00Speaker 12: see more drop off.
- 47:02Speaker 5: So what we did is we took.
- 47:04Speaker 4: All of that data.
- 47:05Speaker 12: We then overlaid voter information on top of that, and
- 47:09Speaker 12: so what we could start to see is, you know,
- 47:12Speaker 12: before again this is before the COVID vaccines even existed,
- 47:16Speaker 12: based on voter information, we knew where there would be
- 47:21Speaker 12: higher uptakes of vaccines compared to you know, in some
- 47:26Speaker 12: regions Red states, Blue states, but even within certain blue
- 47:30Speaker 12: states you could see lower utilization rates because of you know,
- 47:35Speaker 12: people's anti vacs bias even back then, so we knew,
- 47:42Speaker 12: you know, I knew beforehand, you're not going to see
- 47:44Speaker 12: what vaccines going on in this area of the world
- 47:47Speaker 12: even after it's available, because they just don't take They
- 47:52Speaker 12: just in general don't do vaccines.
- 47:56Speaker 8: That's something that goes full circle and where focused today
- 48:01Speaker 8: while at HLTH all about community pharmacy and the fusion
- 48:05Speaker 8: of digital health. That's why Purple APT being part of
- 48:08Speaker 8: this conference and being part of this show is important
- 48:10Speaker 8: that our teams understand while there's an organization out there
- 48:14Speaker 8: that can really make sense of this, but then you
- 48:16Speaker 8: can also bring new insights to these pharmacy decision makers,
- 48:20Speaker 8: these people that are building their businesses to look ahead,
- 48:23Speaker 8: especially during seasons where things like immunizations are really kind
- 48:27Speaker 8: of growing and preparing for that correct and you.
- 48:30Speaker 12: Know, and so you know, that's one of the reasons
- 48:32Speaker 12: why you know, we've come to conferences like health you know,
- 48:35Speaker 12: is to really let people understand that we have a
- 48:37Speaker 12: breadth of data, you know, medical claims, pharmacy claims, you
- 48:41Speaker 12: know that you just don't get access to, you know,
- 48:44Speaker 12: from most of the other data vendors, you know, because
- 48:46Speaker 12: we're at uh you know, it's all de identified. But
- 48:50Speaker 12: because we have the social determinant of health linkage at
- 48:53Speaker 12: the individual drug and at the individual physician level or facility.
- 48:59Speaker 12: Now you can get into site said you can get
- 49:01Speaker 12: from other data services.
- 49:02Speaker 8: If you are in community pharmacy listening to the show,
- 49:05Speaker 8: reach out to Purple Lab purplelab dot com. Ask them
- 49:09Speaker 8: you heard doctor Russell Robbins on the show. You want
- 49:11Speaker 8: more information, Imagine reaching out to a physician through the
- 49:15Speaker 8: data that they give you, and you already know before
- 49:17Speaker 8: you call that physician what gaps there are in care
- 49:22Speaker 8: and being able to use that for business development.
- 49:25Speaker 7: I love this, Russell.
- 49:26Speaker 8: We hoped to obviously continue to have you back every
- 49:28Speaker 8: once in a while educating our listeners.
- 49:30Speaker 7: Purple Lab, doctor Russell Robbins, thanks for being part of
- 49:33Speaker 7: the show.
- 49:33Speaker 12: Thank you, Todd as great to say